Advertisement

World Journal of Surgery

, Volume 42, Issue 8, pp 2469–2475 | Cite as

Adrenal Ganglioneuroma: Features and Outcomes of 42 Cases in a Chinese Population

  • Jing Xie
  • Jun Dai
  • Wen-long Zhou
  • Fu-kang Sun
Original Scientific Report

Abstract

Background

Adrenal ganglioneuromas (AGNs) are extremely rare benign neoplasms. This study is to share our experience regarding diagnostic and operative management of these tumors.

Methods

Clinical details as well as follow-up data were retrospectively analyzed in 42 primary AGN patients who received operative resection at a tertiary referral hospital in China between May 2005 and July 2016.

Results

The mean age of the patients at diagnosis was 35.3 years (range 13–59 years). Among the patients, 28 were asymptomatic. The mean preoperative size was 5.3 ± 2.2 cm (range 2.1–14.0 cm), and 17 cases were larger than 5 cm. All patients underwent operative resection as open adrenalectomy in 20 patients and laparoscopy in 22 patients. The mean tumor size on pathologic examination was 6.0 ± 2.6 cm (range 2.2–17.0 cm). Laparoscopic operation showed its advantages over open surgery on the postoperative duration (5.0 vs. 7.3 days, p < 0.001) and estimated blood loss (69.5 vs. 157.5 ml, p = 0.047). No patient had recurrence or metastasis during a median follow-up of 70.5 months (range 3.7–164.3 months).

Conclusions

We describe the largest AGN series reported to date. The preoperative diagnosis of AGN remains difficult despite of the progression of imaging examination. After complete resection, the prognosis of AGN patients is excellent. Laparoscopic approach has its advantages in the resection of AGNs.

Notes

Acknowledgements

This study was supported by funding from National Natural Science Foundation of China (No. 81572621).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Enzinger FM, Weiss SW (1995) Ganglioneuroma. In: Soft tissue tumors, 3rd edn. St Louis, pp 929–964Google Scholar
  2. 2.
    Geoerger B, Hero B, Harms D et al (2001) Metabolic activity and clinical features of primary ganglioneuromas. Cancer 91:1905–1913CrossRefPubMedGoogle Scholar
  3. 3.
    Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J et al (2006) 1,111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors. Ann N Y Acad Sci 1073:38–46CrossRefPubMedGoogle Scholar
  4. 4.
    Qing Y, Bin X, Jian W et al (2010) Adrenal ganglioneuromas: a 10-year experience in a Chinese population. Surgery 147:854–860CrossRefPubMedGoogle Scholar
  5. 5.
    Lee JH, Chai YJ, Kim TH et al (2016) Clinicopathological features of ganglioneuroma originating from the adrenal glands. World J Surg 40:2970–2975.  https://doi.org/10.1007/s00268-016-3630-y CrossRefPubMedGoogle Scholar
  6. 6.
    Shawa H, Elsayes KM, Javadi S et al (2014) Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre. Clin Endocrinol 80:342–347CrossRefGoogle Scholar
  7. 7.
    Rondeau G, Nolet S, Latour M et al (2010) Clinical and biochemical features of seven adult adrenal ganglioneuromas. J Clin Endocrinol Metab 95:3118–3125CrossRefPubMedGoogle Scholar
  8. 8.
    Linos D, Tsirlis T, Kapralou A et al (2011) Adrenal ganglioneuromas: incidentalomas with misleading clinical and imaging features. Surgery 149:99–105CrossRefPubMedGoogle Scholar
  9. 9.
    Erem C, Kocak M, Cinel A et al (2008) Dopamine-secreting adrenal ganglioneuroma presenting with paroxysmal hypertension attacks. Saudi Med J 29:122–125PubMedGoogle Scholar
  10. 10.
    Koch CA, Brouwers FM, Rosenblatt K et al (2003) Adrenal ganglioneuroma in a patient presenting with severe hypertension and diarrhea. Endocr Relat Cancer 10:99–107CrossRefPubMedGoogle Scholar
  11. 11.
    Diab DL, Faiman C, Siperstein AE et al (2008) Virilizing adrenal ganglioneuroma in a woman with subclinical cushing syndrome. Endocr Pract 14:584–587CrossRefPubMedGoogle Scholar
  12. 12.
    Maweja S, Materne R, Detrembleur N et al (2007) Adrenal ganglioneuroma. A neoplasia to exclude in patients with adrenal incidentaloma. Acta Chir Belg 107:670–674CrossRefPubMedGoogle Scholar
  13. 13.
    Rha SE, Byun JY, Jung SE et al (2003) Neurogenic tumors in the abdomen: tumor types and imaging characteristics. Radiographics 23:29–43CrossRefPubMedGoogle Scholar
  14. 14.
    Guo YK, Yang ZG, Li Y et al (2007) Uncommon adrenal masses: CT and MRI features with histopathologic correlation. Eur J Radiol 62:359–370CrossRefPubMedGoogle Scholar
  15. 15.
    Bin X, Qing Y, Linhui W et al (2011) Adrenal incidentalomas: experience from a retrospective study in a Chinese population. Urol Oncol 29:270–274CrossRefPubMedGoogle Scholar
  16. 16.
    Li L, Shao J, Gu J et al (2014) Adrenal ganglioneuromas: experience from a retrospective study in a Chinese population. Urol J 11:1485–1490PubMedGoogle Scholar
  17. 17.
    Zhang Y, Nishimura H, Kato S et al (2001) MRI of ganglioneuroma: histologic correlation study. J Comput Assist Tomogr 25:617–623CrossRefPubMedGoogle Scholar
  18. 18.
    Metser U, Miller E, Lerman H et al (2006) 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 47:32–37PubMedGoogle Scholar
  19. 19.
    Tessonnier L, Sebag F, Palazzo FF et al (2008) Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours? Eur J Nucl Med Mol Imaging 35:2018–2025CrossRefPubMedGoogle Scholar
  20. 20.
    Katz RL, Shirkhoda A (1985) Diagnostic approach to incidental adrenal nodules in the cancer patient. Results of a clinical, radiologic, and fine-needle aspiration study. Cancer 55:1995–2000CrossRefPubMedGoogle Scholar
  21. 21.
    Harisinghani MG, Maher MM, Hahn PF et al (2002) Predictive value of benign percutaneous adrenal biopsies in oncology patients. Clin Radiol 57:898–901CrossRefPubMedGoogle Scholar
  22. 22.
    Paulsen SD, Nghiem HV, Korobkin M et al (2004) Changing role of imaging-guided percutaneous biopsy of adrenal masses: evaluation of 50 adrenal biopsies. AJR Am J Roentgenol 182:1033–1037CrossRefPubMedGoogle Scholar
  23. 23.
    Hayashi Y, Iwato M, Hasegawa M et al (2001) Malignant transformation of a gangliocytoma/ganglioglioma into a glioblastoma multiforme: a molecular genetic analysis. J Neurosurg 95:138–142CrossRefPubMedGoogle Scholar
  24. 24.
    Zografos GN, Kothonidis K, Ageli C et al (2007) Laparoscopic resection of large adrenal ganglioneuroma. JSLS 11:487–492PubMedPubMedCentralGoogle Scholar
  25. 25.
    Marek-Safiejko M, Safiejko K, Łukaszewicz J et al (2016) A comparison of two approaches to laparoscopic adrenalectomy: lateral transperitoneal versus posterior retroperitoneal approach. Adv Clin Exp Med 25:829–835CrossRefPubMedGoogle Scholar
  26. 26.
    Lairmore TC, Folek J, Govednik CM et al (2016) Improving minimally invasive adrenalectomy: selection of optimal approach and comparison of outcomes. World J Surg 40:1625–1631.  https://doi.org/10.1007/s00268-016-3471-8 CrossRefPubMedGoogle Scholar
  27. 27.
    Vrielink OM, Wevers KP, Kist JW et al (2017) Laparoscopic anterior versus endoscopic posterior approach for adrenalectomy: a shift to a new golden standard? Langenbecks Arch Surg 402:767–773CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2018

Authors and Affiliations

  1. 1.Department of Urology, Shanghai Ruijin HospitalShanghai Jiaotong University School of MedicineShanghaiChina

Personalised recommendations